Nalaganje...
The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous system leading to destruction of myelin sheaths. Natalizumab is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin which has been approved for treatment of relapsing forms of MS. This...
Shranjeno v:
| izdano v: | Clin Transl Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6265353/ https://ncbi.nlm.nih.gov/pubmed/30498920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0216-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|